Keith Andrew Wear, Ph.D., Center for Devices and Radiological Health
For scientific research and regulatory support in the area of ultrasound bone densitometry
Serge Beaucage, Ph.D., Center for Biologics Evaluation and Research
For invention of methods, applications, and reagents of phosphoramidite chemistry, the foundation of PCR and sequencing primers, rapid and efficient solid-phase synthesis of antisense oligonucleotides and their analogues and diagnostic probes
Elliot P. Cowan, Ph.D., Center for Biologics Evaluation and Research
For bringing rapid HIV tests to market to meet a critical public health need and developing policy to facilitate their approval and use
OP-1 Implant HDE Review Team
For outstanding collaboration in the review and recommended approval of a novel implant device
Carol A. Arras, M.S., CDRH
Jan C. Callaway, CDRH
Ann H. Costello, Ph.D., D.M.D., CDRH
Pete L. Hudson, Ph.D., CDRH
Mark N. Melkerson, M.S., CDRH
Diane A. Mitchell, M.D., CDRH
Theodore R. Stevens, M.S., CDRH
Jean Toth-Allen, Ph.D., CDRH
Paul A. Williams, CDRH
Celia M. Witten, Ph.D., M.D., CDRH
Mary Ann Wollerton, M.P.A., CDRH
Barry Cherney, Ph.D., CBER
Harold Dickensheets, Ph.D., CBER
CDR John Hill, Ph.D., CBER **
Gary Kikuchi, Ph.D., CBER
Elizabeth Shores, Ph.D., CBER
Bette Goldman, R.N., M.P.H., CBER
Amy S. Rosenberg, M.D., CBER
Ghanshyam Gupta, Ph.D., CBER
Mercedes A. Serabian, M.S., CBER
James G. Farrelly, Ph.D., CDER
CAPT Debra Lewis, O.D., OC **
Janet L. Witley, Ph.D., OC
CDR Mutahar Shamsi, M.S., ORA **
Susan Walker, M.D., CFSAN
Angel Torres-Cabassa, Ph.D., CDRH
Nirmal Mishra, D.V.M., Ph.D., CDRH
Angelo DePaola, Ph.D.,
Susan A. McCarthy, Ph.D.
For development of non-radioactive gene probes specific for Vibrio parahaemolyticus and utilizing these probes to gather hazard characterization data to facilitate risk assessment
Keith Andrew Wear, Ph.D.
For scientific research and regulatory support in the area of ultrasound bone densitometry
Non-Inferiority Clinical Trial Statistics Development Group
For outstanding achievements in evaluation and development of statistical methods for active control non-inferiority clinical trials significantly enhance the scientific basis for FDA's regulatory decisions
Sue-Jane Wang, Ph.D., CDER
Hsien-Ming James Hung, Ph.D., CDER
Yi Tsong, Ph.D., CDER
Hana Golding, Ph.D.
Frank J. Schenck, B.S., M.S., FDA Southeast Regional Laboratory, Atlanta, Georgia, ORA
For sustained outstanding analytical science accomplishments in quantifying pesticide residues in food using solid phase extraction
Chloramphenicol Residue Work Group, FDA Denver District Laboratory, ORA
For protection of the public's health through the development and implementation of analytical methodology to detect the banned antibiotic chloramphenicol, resulting in regulatory actions
Karen S. Kreuzer
Cathy L. Burns
Allen P. Pfenning
Jose E. Roybal
Sherri B. Turnipseed, Ph.D.
Mark R. Madson
Bryan K. Bowes
J. David Bradley
Susan B. Clark
Lori E. Hibbard
Anthony J. LaGreca
Rebecca H. Lee
William B. Martin, Ph.D.
Lara L. Murphy
Gene J. Nandrea
W. Doug Rowe
Martha H. Schwartz
Virginia L. Sheldon
Joseph M. Storey
SDAR and QSDAR Computational Group
For invention, patenting, development, and licensing of spectral data modeling methods having significant public health impact in rapid estimation of toxicological and pharmacological properties
Richard D. Beger, Ph.D., NCTR
Jon G. Wilkes, Ph.D., NCTR
Dwight W. Miller, Ph.D., NCTR
Jackson O. Lay, Jr., Ph.D., NCTR
Dan A. Buzatu, Ph.D., NCTR
James P. Freeman, Ph.D., NCTR
Magdi Michel Mossoba, Ph.D.
For successful application of novel methodologies in infrared spectroscopy to problems of food composition and safety, including development of rapid screening techniques for pathogenic bacteria
Aldo G. Badano, Ph.D.
For the development of a comprehensive set of quantitative methods for the evaluation of soft copy display systems for medical imaging
Vasculitis Research Unit
For significant advancements in discovering and evaluating practical interspecies biomarkers of drug-induced vascular injury and for substantial contributions to understanding pathogenic mechanisms
Jun Zhang, M.D., CDER
Eugene H. Herman, Ph.D., CDER
Alan D. Knapton, B.A., CDER
Frank D. Sistare, Ph.D., CDER **
Serge Beaucage, Ph.D.
For invention of methods, applications, and reagents of phosphoramidite chemistry, the foundation of PCR and sequencing primers, rapid and efficient solid-phase synthesis of antisense oligonucleotides and their analogues and diagnostic probes
K. Barry Delclos, Ph.D.
For successfully orchestrating a massive interagency project to define the mechanisms for endocrine disruption by important environment chemicals, including drugs and food constituents
Campylobacter Working Group
For the development of the NCCLS approved antimicrobial susceptibility testing method fastidious food borne bacterial pathogen Campylobacter jejuni
Robert D. Walker, M.S., Ph.D., CVM
Patrick F. McDermott, M.S., Ph.D., CVM
Sonya M. Bodeis, B.S., CVM
Francis S. Lin, Ph.D.
For outstanding and continuous contributions as senior toxicologist responsible for safety assessment of food additives, particularly food contact substances
Carol Cunningham Benson, B.S., M.A.
For scientific and technical contribution to improving the analytical soundness of chemistry diagnostics used to measure and monitor diseases
Zili Li, M.D., M.P.H.
For excellence in developing new approaches for analyzing risk information about Lotronex
Elliot P. Cowan, Ph.D.
For bringing rapid HIV tests to market to meet a critical public health need and developing policy to facilitate their approval and use
Michele L. Obert, B.S.E.
For extraordinary talent, ingenuity, and ability while covering domestic and foreign inspections as well as sample analysis
Harlan J. Howard, Ph.D.
For leadership in creating scientific standards, where none existed previously, in evaluating effectiveness and animal safety for reproductive agents used in food animals
Deborah A. Loveys, Ph.D., ORA
For outstanding and continuing contributions to the development and implementation of analytical methods and training related to the detection of bioterrorist pathogens and viral contaminants in FDA regulated products
Chromatography Media Decay Evaluation Team
For outstanding efforts to establish scientific data driven FDA policy on chromatography media reuse in biotechnology product manufacture
Kurt Brorson, Ph.D., CBER
Janice Brown, M.S., CDER
Elizabeth Hamilton, CBER
OP-1 Implant HDE Review Team
For outstanding collaboration in the review and recommended approval of a novel implant device
Carol A. Arras, M.S., CDRH
Jan C. Callaway, CDRH
Ann H. Costello, Ph.D., D.M.D., CDRH
Pete L. Hudson, Ph.D., CDRH
Mark N. Melkerson, M.S., CDRH
Diane A. Mitchell, M.D., CDRH
Theodore R. Stevens, M.S., CDRH
Jean Toth-Allen, Ph.D., CDRH
Paul A. Williams, CDRH
Celia M. Witten, Ph.D., M.D., CDRH
Mary Ann Wollerton, M.P.A., CDRH
Barry Cherney, Ph.D., CBER
Harold Dickensheets, Ph.D., CBER
CDR John Hill, Ph.D., CBER **
Gary Kikuchi, Ph.D., CBER
Elizabeth Shores, Ph.D., CBER
Bette Goldman, R.N., M.P.H., CBER
Amy S. Rosenberg, M.D., CBER
Ghanshyam Gupta, Ph.D., CBER
Mercedes A. Serabian, M.S., CBER
James G. Farrelly, Ph.D., CDER
CAPT Debra Lewis, O.D., OC **
Janet L. Witley, Ph.D., OC
CDR Mutahar Shamsi, M.S., ORA **
Susan Walker, M.D., CFSAN
Angel Torres-Cabassa, Ph.D., CDRH
Nirmal Mishra, D.V.M., Ph.D., CDRH
Coronary Drug-Eluting Stent Regulatory Review Team
For superior intercenter collaboration between CDRH and CDER in developing a regulatory strategy in the scientific review of novel drug-eluting coronary stents, a combination product
Ashley B. Boam, MSBE, CDRH
Xiao-Hong Chen, Ph.D., CDER
Nallaperumal Chidambaram, Ph.D., CDER
Albert Defelice, Ph.D., CDER
Jonette Rogers Foy, Ph.D., CDRH
John Francis Glass, M.P.H., CDRH
Jennifer L. Goode, B.S., CDRH
John E. Hyde, M.D., Ph.D., CDRH
Donald Nick Jensen, D.V.M., M.S., CDRH
Patrick John Marroum, Ph.D., CDER
Kasturi Srinivasachar, Ph.D., CDER
John Edward Stuhlmuller, M.D., CDRH
Belay Tesfamariam, Ph.D., CDER
Douglas C. Throckmorton, M.D., CDER
Carolyn Vaughan, B.S., CDRH
Bram David Zuckerman, M.D., CDRH
** Commissioned Corps
For additional information, please call the Office of Science and Health Coordination at 301-827-3340
POSTER AWARDS FOR THE 2002 FDA SCIENCE FORUM
Presented by the FDA Chapter of Sigma Xi
First Place Poster - 2003 FDA Science Forum
Board O-07
Systemic and Local Drug Delivery Inhibit Vascular Stenosis Following Angioplasty and Grafting: Safety and Effectiveness and Routes of Administration
J.W.Karanian1, N.Kipshidze2, D.Wray-Cahen1, S.L.Hilbert1, A.Ashby1, W.F.Pritchard1, 1OST, CDRH, FDA, 2Lenox Hill Hospital , NY, NY
AbstractSecond Place Poster - 2003 FDA Science Forum
Board F-15
Microbial Source Tracking (MST) of Foodborne Salmonella & Campylobacter
R.Singh, S.L.Foley, D.G.White, S.Zhao, S.Simjee, P.F.McDermott, R.D.Walker, Center for Veterinary Medicine, FDA, Laurel, MD
AbstractThird Place Poster - 2003 FDA Science Forum
Board I-10
Comparative analysis of the detection of vaccinia virus antigens by human polyclonal immune globulin preparations
M.G.Mikolajczyk, N.L.Eller, A.Jones-Trower, M.Kennedy, D.E.Scott, CBER, FDA, Bethesda, MD
AbstractHonorable Mention Poster - 2003 FDA Science Forum
Board G-09
Improved Enrichment for Enterohemorrhagic Escherichia coli (EHEC) by Exposure to Extremely Acidic Conditions
M.A.Grant, ORA, Pacific Regional Laboratory Northwest, FDA, Bothell, WA 98021
AbstractHonorable Mention Poster - 2003 FDA Science Forum
Board B-01
Microarray Detection of Antibiotic Drug Resistant Strains of Mycobacterium tuberculosis (MTB)
X.Tang1, S.L.Morris2, J.J.Langone1, S.A.Khan3, P.M.Regan4, L.E.Bockstahler1, 1CDRH, FDA, Rockville, MD 20857, 2CBER, FDA, Rockville, MD 20857, 3NCTR, FDA, Jefferson, AR 72079, 4WEAC, ORA, FDA, Winchester, MA 01890
AbstractHonorable Mention Poster - 2003 FDA Science Forum
Board I-05
Isolation and Identification of Bacillus anthracis from food
B.D.Tall1, S.Monday1, M.H.Kothary2, D.Hao1, D.E.Hanes2, T.S.Hammack1, D.H.Burr2, 1FDA, College Park, MD, 20740, 2FDA, Laurel, MD, 20708
AbstractPeople's Choice Award - 2003 FDA Science Forum
Board G-12
Transfusion Related Fatalities from Bacterial Contamination of Blood Components
L.E.Simmons, MT(ASCP)1, M.A.Knippen2, L.G.Holness, M.D.3, 1OCBQ, CBER, FDA, Rockville, MD, 2OCBQ, CBER, FDA, Rockville, MD, 3OBRR, CBER, FDA, Rockville, MD
AbstractClear Science Communication Award - 2003 FDA Science Forum
Board A-29
Validation of Methods to Confirm Chloramphenicol at 0.1 ppb in Shrimp, Crabmeat, and Honey: Collaboration between FDA CVM, FDA Office of Regulatory Affairs, Florida Dept. of Agriculture and Consumer Affairs, and the Canadian Food Inspection Agency
M.C.Carson, C.B.Nochetto, D.N.Heller, K.Ferbos, P.J.Kijak, Division of Residue Chemistry, Office of Research, CVM, Laurel MD 20708
AbstractClear Science Communication Award - 2003 FDA Science Forum
Board D-03
Evaluating the Safety and Effectiveness of "Aberration-Free" Ophthalmic Refractive Surgery
B.Drum, M.Eydelman, G.Hilmantel, CDRH, FDA, Rockville, MD
AbstractClear Science Communication Award - 2003 FDA Science Forum
Board T-03
Studies in Pregnant Women: Pharmacokinetic/Pharmacodynamic and Fetal Safety
D.Kennedy, K.Uhl, K.Chapman, M.A.Miller, FDA, Rockville, MD
AbstractClear Science Communication Award - 2003 FDA Science Forum
Board W-08
Did Drugs Withdrawn in Recent Years Have Greater Risk in Women? Findings From Postmarketing Reporting of Adverse Events Data
M.C.Chen1, S.M.Huang2, J.Beitz1, R.Temple3, 1Office of Drug Safety, , 2Office of Clinical Pharmacology and Biopharmaceutics, , 3Office of Medical Policy, CDER, FDA, Rockville, MD
Abstract
2003 FDA Science Forum | FDA Chapter, Sigma Xi | CFSAN | FDA
Last updated on 2003-APR-29 by frf